Key Highlights

Risk & Performance

Pipeline Risk Assessment

Based on historical performance

Low Risk

Score: 25/100

Failure Rate

0.0%

0 terminated/withdrawn out of 7 trials

Success Rate

100.0%

+13.5% vs industry average

Late-Stage Pipeline

43%

3 trials in Phase 3/4

Results Transparency

0 of 3 completed trials have results

Key Signals

Enrollment Performance

Analytics

N/A

3(42.9%)

Phase 4

2(28.6%)

Phase 2

1(14.3%)

Phase 3

1(14.3%)

7Total

N/A(3)

Phase 4(2)

Phase 2(1)

Phase 3(1)

Activity Timeline

Global Presence

Loading network data...

Clinical Trials (7)

Showing 7 of 7 trials

NCT07086235Not ApplicableCompleted

Remineralization Capacity and Patient Satisfaction of Self-Assembling Peptide With Fluoride Versus Tooth Protective Coating With Surface Pre-Reacted Glass on White Spot Lesions

Role: lead

NCT05861297Phase 4Unknown

Immune Thrombocytopenia Management in Adults

Role: lead

NCT05657132Phase 3Unknown

Antibacterial Effect of New Herbal Paste Used as an Intracanal Medication

Role: lead

NCT05623605Phase 4Unknown

Evaluation of New Different Herbal Mouthwashes Against Caries Forming Bacteria, RCT

Role: lead

NCT05517187Not ApplicableUnknown

Efficacy of Regenerative Endodontic Treatment With PRF as a Secondary Treatment of Mature Necrotic Incisors in Adolescents

Role: lead

NCT04169698Phase 2Completed

Alendronate Versus Denosumab in Kidney Transplant Patients

Role: collaborator

NCT04073901Not ApplicableCompleted

Comparative Study Between Zirconia Crowns and Endocrowns in Pulpotomized Primary Molars

Role: lead

All 7 trials loaded